Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy

Diabetic Medicine

Volumn 21, Issue 10, 2004, Pages 1121-1128

  Luzio, Stephen ^a,h   Hatcher, S ^a   Zahlmann, G ^b   Mazik, L ^c   Morgan, M ^d   Liesenfeld, B ^e   Bek, T ^f   Schuell, H ^b   Schneider, S ^b   Owens, D R ^a   Kohner, E ^g  

^a Diabetes Research Unit   (United Kingdom)

^b SIEMENS AG   (Germany)

^c CHARLES UNIVERSITY   (Czech Republic)

^d Irish Diabet Retinopathy Stud Grp   (Ireland)

^e BruderKrankenhaus   (Germany)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Diabetic retinopathy; Quality assurance; Screening; Telemedicine

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CAMERA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; HEALTH CARE PERSONNEL; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT SATISFACTION; PHOTOGRAPHY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; TELECOMMUNICATION; VALIDATION PROCESS;

ADOLESCENT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOGRAPHY; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; TELEMEDICINE;

EID: 6344237399     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01305.x     Document Type: Article

References (23)

1. Amos AF, McCarty D, Zimmet P. The rising global burden of diabetes and its complications; estimates and projections to the year 2010. Diabetic Med 1997; 14 (Suppl. 5): S7-S85.
2. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025; prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-1431.
3. Owens DR, Dolben J, Vora JP, Luzio SD, Williams S, Young S et al. Retinopathy and nephropathy in relationship to metabolic status in newly diagnosed NIDDM. Excerpta Medica 1989; 111-119.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
5. Home PD. Diagnosing the undiagnosed with diabetes. Br Med J 1994; 308: 611-612.
6. Marks L. Counting the Cost: The Real Impact of Non-insulin Dependent Diabetes. London: Kings Fund Policy Unit, 1996.
7. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type 2 diabetes. Diabetologia 2002; 45: S13-S17.
8. O'Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ. Direct medical costs of complications resulting from Type 2 diabetes in the US. Diabetes Care 1998; 21: 1122-1128.
9. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998; 16: 297-303.
10. Kristinsson K. Diabetic retinopathy - screening and prevention of blindness. Acta Ophthalmologica Scand 1977; 75: 223.
11. Javitt JC, Ferris FL, Aeillo L, Canner JK, Chiang Y, Greenfield S. Preventative eye care in people with diabetes is cost saving to the Federal Government. Implications for health reform. Diabetes Care 1994; 17: 909-917.
12. Javitt JC, Aiello L. Cost effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996; 124: 164-169.
13. Porta M, Rizzitiello A, Tomalino M, Trento M, Passera P, Mininne A et al. A comparison of the cost effectiveness of three approaches to screen for sight threatening diabetic retinopathy. Diabetes Metab 1999; 25: 44-53.
14. James M, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic retinopathy. Br Med J 2000; 320: 1627-1631.
15. Bagga P, Verma D, Walton C, Masson EA, Hepburn DA. Survey of diabetic retinopathy screening services in England and Wales. Diabet Med 1998; 15: 780-782.
16. Young S, George LD, Lusty J, Owens DR. A new screening tool for diabetic retinopathy: the Canon CR5 45NM retinal camera with Frost Medical Software RIS-Lite digital imaging system. J Audiovis Media Med 1997; 20: 11-14.
17. Owens DR, Gibbins RL, Kohner E, Grimshaw GM, Greenwood R, Harding S. Diabetic retinopathy screening. Diabet Med 2000; 17: 493-494.
18. Hutchinson A, McIntosh A, Peters J, O'Keeffe C, Khunti K, Baker R et al. Effectiveness of screening and monitoring tests for diabetic retinopathy - a systematic review. Diabet Med 2000; 17: 495-506.
19. Schmidt V, Striebel W, Michelson G, Shanit D. MedStage - an internet-based platform for telemedicine applications. Electromedica 1999; 67(2): 13-16.
20. Gibbins RL, Owens DR, Allen J, Eastman L. Practical application of the European Field Guide in screening for diabetic retinopathy using ophthalmoscopy and 35mm retinal slides. Diabetologia 1998; 41: 59-64.
21. Garvican L, Clowes J, Gillow T. Preservation of sight in diabetes: developing a national risk reduction programme. Diabet Med 2000; 17: 627-634.
22. Grimshaw GM, Baker R, Wilson AD, Thompson JR, Atkinson M. Report of the Inter College Audit of Diabetic Retinopathy Screening. Leicester: Clinical Governance Research and Development Unit, University of Leicester, 1999.
23. Pandit RJ, Taylor R. Quality assurance in screening for sight threatening diabetic retinopathy. Diabet Med 2002; 19: 285-291.